Are you a new member? Sign up now
Login area
| Sign up
close
IMBRUVICA - 420mg - 30
| ATC | B/G | Ingredients | code | Registration Nb | brand_name | Dosage | Presentation | Form | Route | Agent | Laboratory | man_country | Price | Pharmacist Margin | Startum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| L01EL01 | B | Ibrutinib - 420mg | 10597 | 180820/1 | IMBRUVICA | 420mg | 30 | Tablet, film coated | Oral | Mersaco | Cilag AG | Switzerland | 545,551,862 L.L | 2.44 | E2 | Janssen Cilag International NV | Belgium | 2/5/2024 | 0 |
Drug Substitutes
| ATC | B/G | Ingredients | code | Registration Nb | brand_name | Dosage | Presentation | Form | Route | Agent | Laboratory | man_country | Price | Pharmacist Margin | Startum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| L01EL01 | B | Ibrutinib - 420mg | 10597/388 | 180820/1 | IMBRUVICA | 420mg | 30 | Tablet, film coated | Oral | Mersaco | Cilag AG | Switzerland | L.L | 2.44 | E2 | Janssen Cilag International NV | Belgium | 2/5/2024 |
Sitemap
© Copyrights reserved to Ministry of Public Health 2024